UroGen Pharma 2026 年第二季財報前瞻 (NASDAQ:URGN)
· seekingalpha.com
UroGen Pharma (URGN) 預計於 8 月 5 日週三開盤前公佈第二季財報結果。市場共識預期的每股盈餘 (EPS) 為 -$0.27 (年增率 +74.3%)。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...